Mycophenolate mofetil treatment following renal transplantation decreases GTP concentrations in mononuclear leucocytes

Clinical Science

Volumn 107, Issue 1, 2004, Pages 69-74

  Jagodzinski, Piotr ^a   Lizakowski, Slawomir ^a   Smolenski, Ryszard T ^a,c   Slominska, Ewa M ^a   Goldsmith, David ^b   Simmonds, H Anne ^b   Rutkowski, Boleslaw ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b GUY S HOSPITAL   (United Kingdom)

^c HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

GTP; Kidney transplantation; Mononuclear leucocyte; Mycophenolic acid; Purine nucleotide; Pyrimidine nucleotide

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GUANOSINE TRIPHOSPHATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AZATHIOPRINE; CHILD; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; FEMALE; GUANOSINE TRIPHOSPHATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMP DEHYDROGENASE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE PERIOD; PURINE NUCLEOTIDES; PYRIMIDINE NUCLEOTIDES;

EID: 3142748188     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20030332     Document Type: Article

References (17)

1. Sollinger, H. W. (1995) Mycophenolate mofetil for prevention of acute rejection in primary cadaveric renal allograft recipients. Transplantation 60, 225-232
2. European Mycophenolate Mofetil Cooperative Study Group (1995) Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejections. Lancet 345, 1321-1325
3. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group (1996) A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 61, 1029-1037
4. Allison, A. C. and Eugui, E. M. (2000) Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47, 85-118
5. Turka, L. A., Dayton, J. S., Sinclair, G., Thompson, C. B. and Mitchell, B. S. (1991) Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine. J. Clin. Invest. 87, 940-948
6. Laliberte, J., Yee, J., Xiong, Y. and Mitchell, B. S. (1998) Effects of guanine nucleotide depletion on cell cycle progression in human T lymphocytes. Blood 91, 2896-2904
7. Yashima, Y. and Ohgane, T. (2001) Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent. Nippon Yakurigaku Zasshi 117, 131-137
8. Sanquer, S., Breil, M., Baron, C., Dhamane, D., Astier, A. and Lang, P. (1999) Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil. Clin. Pharmacol Ther. 65, 640-648
9. Weigel, G., Griesmacher, A., Zuckermann, A. O., Laufer, G. and Mueller, M. M. (2001) Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients. Clin. Pharmacol. Ther. 69, 137-144
10. Qiu, Y., Fairbanks, L. D., Ruckermann, K. et al. (2000) Mycophenolic acid-induced GTP depletion also affects ATP and pyrimidine synthesis in mitogen-stimulated primary human T-lymphocytes. Transplantation 69, 890-897
11. Montero, C., Duley, J. A., Fairbanks, L. D. et al. (1995) Demonstration of induction of erythrocyte inosine monophosphate dehydrogenase activity in Ribavirin-treated patients using a high performance liquid chromatography linked method. Clin. Chim. Acta 238, 169-178
12. Ruckemann, K., Laurence, A., Fairbanks, L. D. et al. (1998) Biochemical basis for the impaired immune response in chronic renal failure? Adv. Exp. Med. Biol. 431, 559-563
13. Langman, L. J., LeGatt, D. F., Halloran, P. F. and Yatscoff, R. W. (1996) Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients. Transplantation 62, 666-672
14. 13a Goldsmith, D., Carrey, E. A., Edbury, S., Smolenski, R. T., Jagodzinski, P. and Simmonds, H. A. (2004) Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients. Clin. Sci. 107, 63-68
15. Fairbanks, L. D., Bofill, M., Ruckemann, K. and Simmonds, H. A. (1995) Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors. J. Biol. Chem. 270, 29682-29689
16. Carr, S. F., Papp, E., Wu, J. C. and Natsumeda, Y. (1993) Characterization of human type I and type II IMP dehydrogenases. J. Biol. Chem. 268, 27286-27290
17. Mathiew, T. H. for Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group (1998) A blinded, long term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: result at 3 years. Transplantation 65, 1450-1454